RSNA: Toshiba highlights MR technology

| | Health Imaging | Screening

Toshiba America Medical Systems (Booth #3438) is showcasing its Vantage Titan 1.5T MR series and MR tools as works in progress at RSNA 2012, in Chicago, Nov. 25-30.

The Vantage Titan 1.5T series includes the 8-, 16- and 32-channel MR systems and offers an upgrade path from the 8-channel to the 32-channel system.

Toshiba is sharing M-Power User Interface Upgrade, which automates certain steps with routine MR exams, and Pediatric Scan Apparatus, which positions the 16-element coils for pediatric head, neck and spine imaging. Both enhancements are works-in-progress.

The company also is introducing Spot Fluoro, a dose management tool for Infinix-i vascular X-ray systems. Spot Fluoro allows clinicians to view a region of anatomy using live fluoroscopy while viewing the Last Image Hold surrounding area.

 

Related Content

Rising rates of interval breast cancers have experts calling for more risk-based screenings
Rates of breast cancer diagnosis, death expected to climb in coming decades
AI quantifies breast arterial calcifications on mammograms
AI 'not safe' to be implemented as a solo reader for breast cancer screening exams
American College of Radiology announces significant expansion of Lung Cancer Screening Registry
AI beats standard regression models at predicting lung cancer risk

Around the web

Cardiovascular Business
GE HealthCare launches new cardiac CT scanner with advanced AI capabilities

GE HealthCare designed the new-look Revolution Vibe CT scanner to help hospitals and health systems embrace CCTA and improve overall efficiency.

Cardiovascular Business
Bracco updates HeartSee coronary flow capacity software with new diagnostic features

Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.

Cardiovascular Business
Key trends in diagnostic heart testing: CT on the rise as some traditional techniques fall out of favor

The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.